Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
par Dodion, Pierre 
;de Valeriola, Dominique ;Crespeigne, Nadine;Peeters, B;Wery, France ;van Berchem, C;Piccart-Gebhart, Martine ;Tueni, Elias;Joggi, J;Kenis, Y
Référence European journal of cancer & clinical oncology, 24, 6, page (1019-1026)
Publication Publié, 1988-06
;de Valeriola, Dominique ;Crespeigne, Nadine;Peeters, B;Wery, France ;van Berchem, C;Piccart-Gebhart, Martine ;Tueni, Elias;Joggi, J;Kenis, YRéférence European journal of cancer & clinical oncology, 24, 6, page (1019-1026)
Publication Publié, 1988-06
Article révisé par les pairs
| Titre: |
|
| Auteur: | Dodion, Pierre; de Valeriola, Dominique; Crespeigne, Nadine; Peeters, B; Wery, France; van Berchem, C; Piccart-Gebhart, Martine; Tueni, Elias; Joggi, J; Kenis, Y |
| Informations sur la publication: | European journal of cancer & clinical oncology, 24, 6, page (1019-1026) |
| Statut de publication: | Publié, 1988-06 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Administration, Oral |
| Adult | |
| Aged | |
| Antineoplastic Agents -- therapeutic use | |
| Biological Availability | |
| Daunorubicin -- analogs & derivatives | |
| Drug Evaluation | |
| Female | |
| Half-Life | |
| Humans | |
| Leukopenia -- chemically induced | |
| Male | |
| Menogaril | |
| Middle Aged | |
| Neoplasms -- blood | |
| Nogalamycin -- administration & dosage | |
| Nogalamycin -- adverse effects | |
| Nogalamycin -- analogs & derivatives | |
| Nogalamycin -- blood | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0277-5379 |
| info:pmid/2970391 |
